High Prevalence of Vitamin A Deficiency and Vitamin D Deficiency in Patients Evaluated for Liver Transplantation
|
|
- Brendan Bryan
- 5 years ago
- Views:
Transcription
1 LIVER TRANSPLANTATION 19: , 2013 ORIGINAL ARTICLE High Prevalence of Vitamin A Deficiency and Vitamin D Deficiency in Patients Evaluated for Liver Transplantation Mukund Venu, Eric Martin, Kia Saeian, and Samer Gawrieh Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI Deficiencies in vitamins A, D, and E have been linked to night blindness, bone health, and post liver transplant reperfusion injury. The aim of this study was to determine the prevalence and predictive factors of fat-soluble vitamin deficiencies in liver transplant candidates. We reviewed the medical records of liver transplant candidates at our center from January 2008 to September The etiology of cirrhosis, Model for End-Stage Liver Disease score, Child-Pugh class, body mass index (BMI), and vitamin A, vitamin E, and vitamin 25-OH-D levels were recorded. Patients were excluded for incomplete laboratory data, short gut syndrome, celiac disease, pancreatic insufficiency, or prior liver transplantation. Sixty-three patients were included. The most common etiologies of liver disease were alcohol (n 5 23), hepatitis C virus (n 5 19), and nonalcoholic steatohepatitis (n 5 5). Vitamin A and D deficiencies were noted in 69.8% and 81.0%, respectively. Only 3.2% of the patients were vitamin E deficient. There were no documented cases of night blindness. Twenty-five of the 55 patients with bone density measurements had osteopenia, and 10 had osteoporosis. Four patients had vertebral fractures. There was 1 case of posttransplant reperfusion injury in a patient with vitamin E deficiency. In a multivariate analysis, there were no statistically significant predictors for vitamin D deficiency. The Child-Pugh class [odds ratio (OR) , 95% confidence interval (CI) , P ], elevated total bilirubin level (OR , 95% CI , P < 0.001), and elevated BMI (OR , 95% CI , P ) were found to be predictors of vitamin A deficiency. In conclusion, the majority of liver disease patients evaluated for liver transplantation at our center had vitamin A and D deficiencies. The presence or absence of cholestatic liver disease did not predict deficiencies, whereas Child-Pugh class, bilirubin level, and elevated BMI predicted vitamin A deficiency. Liver Transpl 19: , VC 2013 AASLD. Received December 7, 2012; accepted March 11, Malnutrition is commonly encountered in patients with end-stage liver disease (ESLD) and has been reported in up to 80% of all patients with cirrhosis and in up to 25% of patients with Child-Pugh class A cirrhosis. 1,2 It has also been associated with higher morbidity and mortality. 1,2 In fact, the original Child- Turcotte classification included nutritional status as a prognostic parameter. 3 Cirrhosis is associated with a hypermetabolic state, increased protein catabolism, decreased glycogen storage and glucose oxidation, and increased lipid oxidation, all of which contribute to a poor nutritional status, 4 but the precise etiology of malnutrition in patients with cirrhosis is not established. In patients with cirrhosis and chronic cholestasis, there is inadequate delivery of bile salts into the intestinal lumen. This can lead to insufficient absorption and a fat-soluble vitamin deficiency. 5 For example, vitamin A deficiency has been observed in patients with primary biliary cirrhosis (PBC) and may be associated with night blindness. 6,7 Several studies have also shown vitamin D deficiency in both cholestatic and noncholestatic liver disorders It is, however, not clear whether such vitamin deficiencies are due to Abbreviations: AIH, autoimmune hepatitis; BMI, body mass index; CI, confidence interval; ESLD, end-stage liver disease; HCV, hepatitis C virus; MELD, Model for End-Stage Liver Disease; NASH, nonalcoholic steatohepatitis; OR, odds ratio; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis; ROC, receiver operating characteristic. This study was supported in part by grant 1UL1RR from the Clinical and Translational Science Award program of the National Center for Research Resources (National Institutes of Health). Address reprint requests to Samer Gawrieh, M.D., Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI Telephone: ; FAX: ; sgawrieh@mcw.edu DOI /lt View this article online at wileyonlinelibrary.com. LIVER TRANSPLANTATION.DOI /lt. Published on behalf of the American Association for the Study of Liver Diseases VC 2013 American Association for the Study of Liver Diseases.
2 628 VENU ET AL. LIVER TRANSPLANTATION, June 2013 poor nutritional intake, hepatic dysfunction, malabsorption, or a combination of these factors. There are few data on the prevalence of fat-soluble vitamin deficiencies among patients with ESLD awaiting liver transplantation. 11 The aims of this study were to assess the prevalence of fat-soluble vitamin deficiencies in patients being evaluated for liver transplantation and to elucidate the predictive factors for any such deficiencies. PATIENTS AND METHODS We retrospectively reviewed the charts of patients who presented for an outpatient evaluation for liver transplantation at the Medical College of Wisconsin Hepatology Clinic from January 2008 to September The study protocol was reviewed and approved by the institutional review board of the Medical College of Wisconsin. The etiology of cirrhosis, Model for End- Stage Liver Disease (MELD) score, Child-Pugh score, body mass index (BMI), and vitamin A, vitamin E, and vitamin 25-OH-D levels were recorded. Patient demographics, including age, sex, smoking history, alcohol use, and drug use, were reviewed. Serum vitamin A and E levels were determined via high-pressure liquid chromatography with ultraviolet detection (Agilent Technologies, Santa Clara, CA). Serum vitamin D 25-OH levels were determined with a radioimmunoassay (DiaSorin, Stillwater, MN). Vitamin A, D, and E deficiencies were defined as levels < 19 lg/dl, < 32 ng/ml, and < 3 mg/l, respectively, and were based on normal ranges used at our institution. A severe vitamin D deficiency was defined as a level < 10 ng/ml. Patients were excluded if they had short gut syndrome, celiac disease, pancreatic insufficiency, a previous liver transplant, or an incomplete laboratory analysis. Statistical Analysis Univariate comparisons of patient characteristics between vitamin-deficient and nondeficient subjects were performed with the Student t test for continuous variables (age, BMI, and MELD score), with the chisquare test for binary variables [sex; race; alanine transaminase, aspartate transaminase, bilirubin, albumin, and alkaline phosphate levels; and contributions of alcohol, nonalcoholic steatohepatitis (NASH), hepatitis C virus (HCV), and primary sclerosing cholangitis (PSC) to the disease etiology], and with the Wilcoxon rank-sum test for ordinal variables (Child-Pugh score). The exact chi-square test was used when the expected number of subjects in a category was 5 or fewer. Similar methods were used for the comparison of excluded and included subjects. Logistic regression was used for the multivariate analysis of predictors of vitamin deficiencies. Due to the large number of potential predictors, model building was performed by forward stepwise selection with a 10% significance level for entry and a 5% significance level for staying in the model. The predictive power of the final model for vitamin A deficiency was evaluated with a receiver operating characteristic (ROC) analysis. All analyses were performed with SAS 9.2 (SAS Institute, Cary, NC). RESULTS Sixty-three of the 211 patients referred for liver transplantation met the inclusion criteria. Incomplete laboratory data (139 patients) were the most common reason for exclusion, and this was due to the varying adherence of different providers in our practice to screening and was not based on a clinical suspicion of vitamin deficiency. Subjects characteristics are summarized in Table 1. There were no statistically significant differences in age, race, sex, BMI, etiology of liver disease, Child-Pugh class, MELD score, alcohol use, or smoking history between the included and excluded subjects. The most common etiologies of chronic liver disease were alcohol abuse (n 5 23) and HCV (n 5 19; Table 2). The remaining patients had HCV and alcohol (n 5 5), NASH (n 5 5), PSC (n 5 4), PBC (n 5 2), NASH and PBC (n 5 1), autoimmune hepatitis (AIH; n 5 2), hepatic carcinoid tumor (n 5 1), or AIH and PSC (n 5 1). None of the included patients had acute liver disease or failure. The majority of the patients were deficient in vitamin A and vitamin D (69.8% and 81.0%, respectively); however, only 2 of the 63 patients (3.2%) were vitamin E deficient, and both had PSC. More than half of the patients were deficient in both vitamin A and vitamin D (36/63 or 57.1%). A severe vitamin D deficiency (<10 ng/ml) was found in only 4 patients (6.3%). When 20 ng/ml was used as the lower limit of normal for defining vitamin D deficiency, 47 of 63 patients (75%) were deficient. The one patient who was underweight but had normal fat-soluble vitamin levels had HCV cirrhosis. There were no documented cases of night blindness in our cohort. Vertebral fractures were documented in 4 patients, all of whom were vitamin D deficient. Bone density data, as measured by dual-energy X-ray absorptiometry scanning, were available for 55 patients. Osteopenia was noted in 25 patients, and osteoporosis was seen in 10 patients, whereas normal bone density was noted in 20 patients. In this group with bone density data, vitamin D deficiency was noted in 18 of the 25 patients (72%) with osteopenia, in 10 of the 10 patients (100%) with osteoporosis, and in 16 of the 20 patients (80%) with normal bone density. Vertebral fractures were documented in 4 patients, all of whom had vitamin D deficiency and osteopenia on a dual-energy X-ray absorptiometry scan. One of our patients who had vitamin E deficiency before transplantation had a reperfusion injury postoperatively. Most patients were not on any vitamin supplementation (40/63 or 63.5%) before their assessment at the hepatology clinic. Seventeen patients (27.0%) were taking a multivitamin supplement. However, 13 of
3 LIVER TRANSPLANTATION, Vol. 19, No. 6, 2013 VENU ET AL. 629 TABLE 1. Vitamin Deficiencies by Patient Characteristics Vitamin A (n 5 63) Vitamin D (n 5 63) Vitamin E (n 5 63) Total Variable (n 5 63) <19 lg/dl (n 5 44 or 69.8%) lg/dl (n 5 19 or 30.2%) <32 ng/ml (n 5 51 or 81.0%) ng/ml (n 5 12 or 19.0%) <3 mg/l (n 5 2 or 3.2%) 3-15 mg/l (n 5 61 or 96.8%) Age [n (%)] years 3 (4.8) 2 (3.2) 1 (1.6) 3 (4.8) 0 1 (1.6) 2 (3.2) years 3 (4.8) 2 (3.2) 1 (1.6) 2 (3.2) 1 (1.6) 0 3 (4.8) years 48 (76.2) 34 (54.0) 14 (22.2) 39 (61.9) 9 (14.3) 1 (1.6) 47 (74.6) 60 years 9 (14.3) 6 (9.5) 3 (4.8) 7 (11.1) 2 (3.2) 0 9 (14.3) Total age (years)* Sex [n (%)] Male 43 (68.3) 30 (47.6) 13 (20.6) 33 (52.4) 10 (15.9) 1 (1.6) 42 (66.7) Female 20 (31.7) 14 (22.2) 6 (9.5) 18 (28.6) 2 (3.2) 1 (1.6) 19 (30.2) Race [n (%)] Caucasian 49 (77.8) 35 (55.6) 14 (22.2) 38 (60.3) 11 (17.5) 2 (3.2) 47 (74.6) African American 7 (11.1) 5 (7.9) 2 (3.2) 7 (11.1) (11.1) Hispanic 4 (6.3) 3 (4.8) 1 (1.6) 3 (4.8) 1 (1.6) 0 4 (6.3) Native American 2 (3.2) 1 (1.6) 1 (1.6) 2 (3.2) (3.2) Middle Eastern 1 (1.6) 0 1 (1.6) 1 (1.6) (1.6) BMI [n (%)] Underweight: <18.5 kg/m 2 1 (1.6) 0 1 (1.6) 0 1 (1.6) 0 1 (1.6) kg/m 2 14 (22.2) 10 (15.9) 4 (6.3) 11 (17.5) 3 (4.8) 0 14 (22.2) Overweight: kg/m 2 22 (34.9) 14 (22.2) 8 (12.7) 20 (31.7) 2 (3.2) 2 (3.2) 20 (31.7) Obese: kg/m 2 21 (33.3) 16 (25.4) 5 (7.9) 15 (23.8) 6 (9.5) 0 21 (33.3) Morbidly obese: 40 kg/m 2 5 (7.9) 4 (6.3) 1 (1.6) 5 (7.9) (7.9) Total BMI (kg/m 2 )* Alcohol use [n (%)] Active 5 (7.9) 4 (6.3) 1 (1.6) 4 (6.3) 1 (1.6) 0 5 (7.9) Former 32 (50.8) 24 (38.1) 8 (12.7) 26 (41.3) 6 (9.5) 0 32 (50.8) Never 26 (41.3) 16 (25.4) 10 (15.9) 21 (33.3) 5 (7.9) 2 (3.2) 24 (38.1) Smoking use [n (%)] Active 6 (9.5) 6 (9.5) 0 6 (9.5) (9.5) Former 29 (46.0) 18 (28.6) 11 (17.5) 24 (38.1) 5 (7.9) 0 29 (46.0) Never 28 (44.4) 20 (31.7) 8 (12.7) 21 (33.3) 7 (11.1) 2 (3.2) 26 (41.3) NOTE: All percentages are based on the total group value (n 5 63). *The data are presented as means and standard deviations.
4 630 VENU ET AL. LIVER TRANSPLANTATION, June 2013 TABLE 2. Vitamin Deficiency by Liver Disease Etiology and Severity Vitamin A (n 5 63) Vitamin D (n 5 63) Vitamin E (n 5 63) Total Variable (n 5 63) <19 lg/dl (n 5 44 or 69.8%) lg/dl (n 5 19 or 30.2%) <32 ng/ml (n 5 51 or 80.9%) ng/ml (n 5 12 or 19.1%) <3 mg/l (n 5 2 or 3.2%) 3-15 mg/l (n 5 61 or 96.8%) Etiology [n (%)] Alcohol 23 (36.5) 20 (31.7) 3 (4.8) 17 (27.0) 6 (9.5) 0 23 (36.5) HCV 19 (30.2) 11 (17.5) 8 (12.7) 16 (25.4) 3 (4.8) 0 19 (30.2) Alcohol and HCV 5 (7.9) 3 (4.8) 2 (3.2) 4 (6.3) 1 (1.6) 0 5 (7.9) NASH 5 (7.9) 3 (4.8) 1 (1.6) 4 (6.3) 1 (1.6) 0 5 (7.9) PSC 4 (6.3) 2 (3.2) 2 (3.2) 4 (6.3) 0 2 (3.2) 2 (3.2) PBC 2 (3.2) 2 (3.2) 0 2 (3.2) (3.2) AIH 2 (3.2) 1 (1.6) 1 (1.6) 1 (1.6) 1 (1.6) 0 2 (3.2) Hepatic carcinoid 1 (1.6) 0 1 (1.6) 1 (1.6) (1.6) AIH and PSC 1 (1.6) 1 (1.6) 0 1 (1.6) (1.6) NASH and PBC 1 (1.6) 1 (1.6) 0 1 (1.6) (1.6) MELD score [n (%)] <15 29 (46.0) 18 (28.6) 11 (17.4) 24 (38.1) 5 (7.9) 0 27 (42.9) (33.3) 16 (25.4) 5 (7.9) 16 (25.4) 5 (7.9) 2 (3.2) 19 (30.2) (19.0) 9 (14.3) 3 (4.8) 11 (17.5) 1 (1.6) 0 12 (19.0) (1.6) 1 (1.6) (1.6) 0 1 (1.6) Total MELD score* Child-Pugh class [n (%)] A 14 (22.2) 5 (7.9) 9 (14.3) 12 (19.0) 2 (3.2) 0 14 (22.2) B 38 (60.3) 28 (44.4) 10 (15.9) 36 (70.6) 2 (3.2) 1 (1.6) 37 (58.7) C 11 (17.5) 11 (17.5) 0 3 (4.8) 8 (12.7) 1 (1.6) 10 (15.9) NOTE: All percentages are based on the total group value (n 5 63). *The data are presented as means and standard deviations.
5 LIVER TRANSPLANTATION, Vol. 19, No. 6, 2013 VENU ET AL. 631 TABLE 3. Multivariate Analysis of Predictors of Vitamin A Deficiency: Stepwise Logistic Regression Results Variable OR (95% CI) P Value Child-Pugh class 6.84 ( ) 0.01 Total bilirubin level ( ) <0.001 BMI 1.17 ( ) these 17 patients (76.5%) were vitamin D deficient, 12 (70.6%) were vitamin A deficient, and 3 (17.6%) had no vitamin deficiencies. The amounts of fat-soluble vitamins in the multivitamin pills and patients compliance with taking them could not be determined from the chart review. Only 6 patients were taking vitamin D (5 of whom were on >1000 IU/day dosing), and 2 patients were taking vitamin E supplementation. Compliance with taking these supplements could not be verified. In the limited number of patients in this cohort who had follow-up data, oral supplementation with vitamins A and D resulted in the correction of vitamin A and D deficiencies in 3 of 5 patients (60%) and 12 of 16 of patients (75%), respectively. All patients with Child-Pugh class C cirrhosis (n 5 11) were deficient in vitamin A. In a multivariate analysis, there were no statistically significant predictors for vitamin D deficiency. The Child-Pugh class [odds ratio (OR) , 95% confidence interval (CI) , P ], an elevated total bilirubin level (OR , 95% CI , P < 0.001), and an elevated BMI (OR , 95% CI , P ) were found to be predictors of vitamin A deficiency (Table 3). With the full model (including the Child-Pugh class, bilirubin level, and BMI), the area under the ROC curve for this model was (95% CI ), and it was higher than the areas of models including the Child-Pugh class and bilirubin level (0.8714, 95% CI ) or the bilirubin level alone (0.7817, 95% CI ; Fig. 1). DISCUSSION The majority of ESLD patients evaluated for liver transplantation at our center were deficient in vitamin A and vitamin D. The Child-Pugh class, the serum bilirubin level, and an elevated BMI were predictors of vitamin A deficiency. There were no predictors for vitamin D deficiency. Interestingly, the etiology of liver disease was not predictive of a fat-soluble vitamin deficiency. Malnutrition has been established as a negative prognostic indicator in patients with ESLD Previous studies have evaluated fat-soluble vitamin deficiencies in patients with chronic cholestatic liver disorders, in which impaired bile flow is the proposed underlying mechanism leading to malabsorption of fat-soluble vitamins. Few studies have evaluated this Figure 1. ROC graph for models predicting vitamin A deficiency. in patients with noncholestatic liver diseases, and most have focused on vitamin D deficiency. Fisher and Fisher 9 evaluated 100 consecutive patients with noncholestatic liver disease for vitamin D deficiency. The most common etiologies of liver disease were alcohol (n 5 40) and HCV (n 5 38). Vitamin D deficiency was found in 68 patients and was more prevalent in patients with Child-Pugh class C cirrhosis. Malham et al. 8 sought to compare vitamin D deficiency in patients with noncholestatic liver disease and patients with cholestatic liver disease. In that study, 89 patients with alcoholic cirrhosis and 34 patients with PBC were retrospectively evaluated for vitamin D deficiency. Vitamin D deficiency was more prevalent in patients with alcoholic cirrhosis versus patients with PBC (85% versus 60%). Arteh et al. 10 evaluated vitamin D deficiency in 118 consecutive patients with HCV. They found that 109 of the 118 patients (92%) had vitamin D deficiency, with severe vitamin deficiency (<7 ng/ml) more common in patients with cirrhosis. A high incidence of vitamin A and D deficiencies was also reported in a recent study by Abbott-Johnson et al. 11 In that study, 107 patients with ESLD who were awaiting liver transplantation were prospectively followed; 75% of the patients were deficient in vitamin A, 66% were deficient in vitamin D, and only 3% were deficient in vitamin E. Similarly to our findings, the severity of the underlying liver disease, as reflected by the Child-Pugh class, was found to be a predictor of fat-soluble vitamin deficiencies. In agreement with prior studies, the majority of our patients with ESLD who were evaluated for liver transplantation were found to be deficient in both vitamin A (69.8%) and vitamin D (81%), but the proportion of patients with vitamin E deficiency was low (3.2%). The MELD score and the presence or absence of cholestatic liver disease were not found to be predictive of vitamin deficiencies in our patients.
6 632 VENU ET AL. LIVER TRANSPLANTATION, June 2013 A fat-soluble vitamin deficiency may have significant clinical consequences. Osteoporosis is a potential complication after liver transplantation. By causing secondary hyperparathyroidism, vitamin D deficiency before liver transplantation may increase the risk for osteoporosis and fractures. 19 There was a high rate of osteoporosis and osteopenia in our patients, and 4 subjects (6.3%) had vertebral fractures. In a recent study, Kaemmerer et al. 20 evaluated the impact of ibandronate, vitamin D3, and calcium supplements before and after liver transplantation on 31 patients with osteopenia or osteoporosis before transplantation. This regimen increased bone mineral density in the lumbar spine up to 12 months after transplantation, and after 24 months, there were only 2 reported cases of fractures within this group. Although there were no documented cases of night blindness in our patients with vitamin A deficiency, none of them underwent a formal ophthalmological evaluation. A study by Abbott-Johnson et al. 7 evaluated vitamin A deficiency and night blindness in 8 patients with cirrhosis awaiting liver transplantation. Interestingly, 6 of the 8 patients were unaware of impairments in their vision. All the patients showed improvements with dark adaptation after intramuscular supplementation with vitamin A. One of our 2 patients with vitamin E deficiency had a reperfusion injury after liver transplantation. Interestingly, Goode et al. 21 demonstrated an increased risk of reperfusion injury after liver transplantation in patients with vitamin E deficiency before transplantation. We found no predictors for vitamin D deficiency, and this was contrary to previous studies that had identified cirrhosis, female sex, and African American race as predictors for vitamin D deficiency. 10,22 Dietary insufficiency, malabsorption, impaired hepatic hydroxylation of vitamin D, and a lack of sunlight exposure may contribute to vitamin D deficiency. Although no predictors for vitamin A deficiency were identified in prior reports, an advanced Child-Pugh class, the total bilirubin level, and an elevated BMI were associated with it in our cohort. It is unclear why Child-Pugh class C patients had a lower frequency of vitamin D deficiency and a higher frequency of vitamin A deficiency in comparison with Child-Pugh class A and B patients. Our study has several limitations. We were unable to find data in the reviewed medical records concerning the adequacy of oral intake or other parameters for assessing nutritional status such as pre-albumin, triceps skinfold thickness, and midarm muscle circumference. Our patient population is located in Wisconsin (at a latitude of 43 N), and this may affect the prevalence of vitamin D deficiency because the reduced exposure to sunlight may contribute to lower vitamin D levels. Vitamin E deficiency was not evident in our patient population. There are conflicting studies on whether the serum measurement of a-tocopherol or the a-tocopherol/total lipid ratio is a more accurate measure of vitamin E in patients with chronic liver disease. 23,24 Serum lipid panels from our patient population were not analyzed, and we did not calculate this ratio to elucidate whether more patients had vitamin E deficiency. Our study was designed not to evaluate the mechanism for these deficiencies but instead to identify whether these patients had significant deficiencies in fat-soluble vitamins. Although an elevated BMI was identified as a predictor of vitamin A deficiency, our BMI calculation was not adjusted for fluid retention. Finally, the exact composition of each patient s multivitamin was unknown; therefore, it is unclear how much impact, if any, these supplements may have had on serum values of fat-soluble vitamins. If our findings are validated in other studies, universal screening for vitamins A and D in this population of patients being evaluated for liver transplantation may be reasonable because of the high prevalence of these deficiencies. Whether vitamin E deficiency is limited only to patients with PSC also needs to be examined in order to make recommendations on appropriate screening. Whether using a daily multivitamin supplement will reduce these deficiencies has not been prospectively studied; however, it did not seem to affect vitamin A and D deficiencies in a subgroup of our patients. In summary, our study confirms that deficiencies of vitamins A and D in patients with ESLD awaiting liver transplantation are very common. The etiology of liver disease did not predict vitamin deficiencies; however, the severity of liver disease affected vitamin A deficiency. The identification and correction of these common deficiencies may be important elements in efforts to optimize this highly morbid patient population before liver transplantation. REFERENCES 1. Kalaitzakis E, Simren M, Olsson R, Henfridsson P, Hugosson I, Bengtsson M, Bj ornsson E. Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life. Scand J Gastroenterol 2006;41: Guglielmi FW, Panella C, Buda A, Budillon G, Caregaro L, Clerici C, et al. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the Nutritional Problems in Gastroenterology section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 2005;37: Kondrup J. Nutrition in end stage liver disease. Best Pract Res Clin Gastroenterol 2006;20: Tsiaousi ET, Hatzitolios AI, Trygonis SK, Savopoulos CG. Malnutrition in end stage liver disease: recommendations and nutritional support. J Gastroenterol Hepatol 2008;23: Maillette de Buy Wenniger L, Beuers U. Bile salts and cholestasis. Dig Liver Dis 2010;42: Herlong HF, Russell RM, Maddrey WC. Vitamin A and zinc therapy in primary biliary cirrhosis. Hepatology 1981;1: Abbott-Johnson WJ, Kerlin P, Abiad G, Clague AE, Cuneo RC. Dark adaptation in vitamin A-deficient adults awaiting liver transplantation: improvement with intramuscular vitamin A treatment. Br J Ophthalmol 2011;95: Malham M, Jïrgensen SP, Ott P, Agnholt J, Vilstrup H, Borre M, Dahlerup JF. Vitamin D deficiency in cirrhosis
7 LIVER TRANSPLANTATION, Vol. 19, No. 6, 2013 VENU ET AL. 633 relates to liver dysfunction rather than aetiology. World J Gastroenterol 2011;17: Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007;5: Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010;55: Abbott-Johnson W, Kerlin P, Clague A, Johnson H, Cuneo R. Relationships between blood levels of fat soluble vitamins and disease etiology and severity in adults awaiting liver transplantation. J Gastroenterol Hepatol 2011;26: Pikul J, Sharpe MD, Lowndes R, Ghent CN. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation 1994;57: Harrison J, McKiernan J, Neuberger JM. A prospective study on the effect of recipient nutritional status on outcome in liver transplantation. Transpl Int 1997;10: Caregaro L, Alberino F, Amodio P, Merkel C, Bolognesi M, Angeli P, Gatta A. Malnutrition in alcoholic and virusrelated cirrhosis. Am J Clin Nutr 1996;63: Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G, Caregaro L. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001;17: Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology 1996;23: Selberg O, B ottcher J, Tusch G, Pichlmayr R, Henkel E, M uller MJ. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997;25: Figueiredo F, Dickson ER, Pasha T, Kasparova P, Therneau T, Malinchoc M, et al. Impact of nutritional status on outcomes after liver transplantation. Transplantation 2000;70: Compston JE. Osteoporosis after liver transplantation. Liver Transpl 2003;9: Kaemmerer D, Benjamin S, Gabriele L, Gunter W, Utz S, Merten H. Treatment of bone loss in patients with chronic liver disease awaiting liver transplantation. Transplant Res 2012;1: Goode HF, Webster NR, Howdle PD, Leek JP, Lodge JP, Sadek SA, Walker BE. Reperfusion injury, antioxidants and hemodynamics during orthotopic liver transplantation. Hepatology 1994;19: Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, Arch Intern Med 2009;169: Look MP, Reichel C, von Falkenhausen M, Hahn C, Stockinger K, von Bergmann K, et al. Vitamin E status in patients with liver cirrhosis: normal or deficient? Metabolism 1999;48: Nagita A, Ando M. Assessment of hepatic vitamin E status in adult patients with liver disease. Hepatology 1997;26:
Bone Mineral Density in Thai Patients with Chronic Hepatitis C, before and after Treatment with Pegylated Interferon/Ribavirin Combination ABSTRACT
Original Article 73 before and after Treatment with Pegylated Interferon/Ribavirin Combination Bunchorntavakul C 1 Chotiyaputta W 1 Sriussadaporn S 2 Tanwandee T 1 ABSTRACT Background: Loss of bone mineral
More informationProspective study of profile of hepatic osteodystrophy in patients with non-choleastatic liver cirrhosis and impact of bisphosphonate supplementation
Original Article Prospective study of profile of hepatic osteodystrophy in patients with non-choleastatic liver cirrhosis and impact of bisphosphonate supplementation United European Gastroenterology Journal
More informationWhat Is the Real Gain After Liver Transplantation?
LIVER TRANSPLANTATION 15:S1-S5, 9 AASLD/ILTS SYLLABUS What Is the Real Gain After Liver Transplantation? James Neuberger Organ Donation and Transplantation, NHS Blood and Transplant, Bristol, United Kingdom;
More informationNUTRITIONAL OPTIMIZATION IN PRE LIVER TRANSPLANT PATIENTS
NUTRITIONAL OPTIMIZATION IN PRE LIVER TRANSPLANT PATIENTS ACHIEVING NUTRITIONAL ADEQUACY Dr N MURUGAN Consultant Hepatologist Apollo Hospitals Chennai NUTRITION IN LIVER FAILURE extent of problem and consequences
More informationORIGINAL ARTICLE. Eric F. Martin, 1 Jonathan Huang, 3 Qun Xiang, 2 John P. Klein, 2 Jasmohan Bajaj, 4 and Kia Saeian 1
LIVER TRANSPLANTATION 18:914 929, 2012 ORIGINAL ARTICLE Recipient Survival and Graft Survival are Not Diminished by Simultaneous Liver-Kidney Transplantation: An Analysis of the United Network for Organ
More informationAssociation of vitamin-d levels with the severity of liver disease
Original article: Association of vitamin-d levels with the severity of liver disease Jayagowri Karthikeyan, Sujatha Rajaragupathy Department of Biochemistry, PSG Institute of medical sciences and research,
More informationAmmonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis
Gastroenterology Report, 5(3), 2017, 232 236 doi: 10.1093/gastro/gow010 Advance Access Publication Date: 1 May 2016 Original article ORIGINAL ARTICLE Ammonia level at admission predicts in-hospital mortality
More informationI have no disclosures relevant to this presentation LIVER TESTS: WHAT IS INCLUDED? LIVER TESTS: HOW TO UTILIZE THEM OBJECTIVES
LIVER TESTS: HOW TO UTILIZE THEM I have no disclosures relevant to this presentation José Franco, MD Professor of Medicine, Surgery and Pediatrics Medical College of Wisconsin OBJECTIVES Differentiate
More informationBariatric Surgery For Patients With End-Organ Failure
Bariatric Surgery For Patients With End-Organ Failure Arnold D. Salzberg, M.D. Andrew M. Posselt, M.D., PhD Divisions of Transplant and Minimally Invasive Surgery University of California, San Francisco
More informationNonalcoholic Fatty Liver Disease in Children: Typical and Atypical
Nonalcoholic Fatty Liver Disease in Children: Typical and Atypical Disclosure Naim Alkhouri, MD discloses the following relationships with commercial companies: Membership in the Speakers Bureau for Alexion
More informationFrequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
GASTROENTEROLOGY 2011;141:1249 1253 Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States MICHAEL R. CHARLTON,* JUSTIN M. BURNS, RACHEL A. PEDERSEN, KYMBERLY
More informationCopyright 2014 ChaBiotech. All Rights Reserved. 차의과학대학교분당차병원소화기내과이주호, MD, PhD
Copyright 2014 ChaBiotech. All Rights Reserved. 차의과학대학교분당차병원소화기내과이주호, MD, PhD Contents 1. Prevalence of Malnutrition in End Stage Liver Disease 2. Assessment of Malnutrition in Liver cirrhosis 3. Prognosis
More informationPrimary Sclerosing Cholangitis Medical Management
Primary Sclerosing Cholangitis Medical Management Kapil Chopra M.D. Assistant Professor of Medicine Division of Transplant Medicine Mayo Clinic Arizona PSC Primary sclerosing cholangitis is a progressive
More informationImpact of Chronic Liver Disease and Cirrhosis on Health Utilities Using SF-6D and the Health Utility Index
LIVER TRANSPLANTATION 14:321-326, 2008 ORIGINAL ARTICLE Impact of Chronic Liver Disease and Cirrhosis on Health Utilities Using SF-6D and the Health Utility Index Amy A. Dan, 1,2 Jillian B. Kallman, 1,2
More informationPrimary sclerosing cholangitis (PSC) is a chronic
Predicting Clinical and Economic Outcomes After Liver Transplantation Using the Mayo Primary Sclerosing Cholangitis Model and Child-Pugh Score Jayant A. Talwalkar, * Eric Seaberg, W. Ray Kim, * and Russell
More informationThe Effect of Liver Transplantation on Autonomic Dysfunction in Patients with End-Stage Liver Disease
LIVER TRANSPLANTATION 14:235-239, 2008 ORIGINAL ARTICLE The Effect of Liver Transplantation on Autonomic Dysfunction in Patients with End-Stage Liver Disease Elizabeth J. Carey, Manjushree Gautam, 3 Timothy
More informationDEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN
October 2-4, Liverpool, UK EURO SPINE 2013 DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN D. Colangelo, L. A. Nasto, M. Mormando, E.
More informationResearch Article New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database
Transplantation Volume 2013, Article ID 269096, 7 pages http://dx.doi.org/10.1155/2013/269096 Research Article New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients:
More informationLevothyroxine replacement dosage determination after thyroidectomy
The American Journal of Surgery (2013) 205, 360-364 Midwest Surgical Association Levothyroxine replacement dosage determination after thyroidectomy Judy Jin, M.D. a, Matthew T. Allemang, M.D. b, Christopher
More informationSevere Muscle Depletion in Patients on the Liver Transplant Wait List: Its Prevalence and Independent Prognostic Value
LIVER TRANSPLANTATION 18:1209-1216, 2012 ORIGINAL ARTICLE Severe Muscle Depletion in Patients on the Liver Transplant Wait List: Its Prevalence and Independent Prognostic Value Puneeta Tandon, 1,2 Michael
More informationCIRROSI E IPERTENSIONE PORTALE NELLA DONNA
Cagliari, 16 settembre 2017 CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Vincenza Calvaruso, MD, PhD Ricercatore di Gastroenterologia Gastroenterologia & Epatologia, Di.Bi.M.I.S. Università degli Studi di
More informationNutritional Issues in Cholestatic Disease
THE HOSPITAL FOR SICK CHILDREN Nutritional Issues in Cholestatic Disease NASPGHAN-CPNP Joint Session Binita M. Kamath, MBBChir MRCP MTR Associate Professor Division of Gastroenterology, Hepatology and
More informationFat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy
Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy Goals Share an interesting case Important because it highlights a common problem that we re likely to
More informationNutritional Issues In Advanced Liver Disease. Corrie Clark, RDN, LD
Nutritional Issues In Advanced Liver Disease Corrie Clark, RDN, LD Objectives List specific points to keep in mind when assessing the nutritional status of patients with advanced liver disease. Describe
More informationLiver Transplantation for Alcoholic Liver Disease in the United States: 1988 to 1995
Liver Transplantation for Alcoholic Liver Disease in the United States: 1988 to 1995 Steven H. Belle, Kimberly C. Beringer, and Katherine M. Detre T he Scientific Liver Transplant Registry (LTR) was established
More informationOriginal Article. Nutritional status and prognosis in cirrhotic patients
Tropical Gastroenterology 2012;33(4):257 264 Original Article Nutritional status and prognosis in cirrhotic patients Madhu Sasidharan, 1 Srinivas Nistala, 1 Narendhran RT, 1 Murugesh M, 1 Shobna J Bhatia,
More informationAlcoholic Liver Disease as First Indication
Alcoholic Liver Disease as First Indication Patrizia Burra Multivisceral Transplant Unit Gastroenterology Department of Surgery, Oncology and Gastroenterology Padua University Hospital, Padua, Italy Patrizia
More informationNutrition in Liver Disease An overview of the EASL Clinical Practice Guidelines
Nutrition in Liver Disease An overview of the EASL Clinical Practice Guidelines Marike Bauermeister Registered Dietitian Wits Donald Gordon Medical Centre Malnutrition Malnutrition is a complication in
More informationESPEN Guidelines on Enteral Nutrition: Liver disease $
Clinical Nutrition (2006) 25, 285 294 http://intl.elsevierhealth.com/journals/clnu ESPEN GUIDELINES ESPEN Guidelines on Enteral Nutrition: Liver disease $ M. Plauth a,, E. Cabré b, O. Riggio c, M. Assis-Camilo
More informationPrevalence of Comorbidities among HIV-positive patients in Taiwan
Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity
More informationEvaluation of Renal Profile in Liver Cirrhosis Patients: A Clinical Study
Original article: Evaluation of Renal Profile in Liver Cirrhosis Patients: A Clinical Study Mukesh Agarwal Assistant Professor, Department of General Medicine, Teerthanker Mahaveer Medical College & Research
More informationNonalcoholic Steatohepatitis National Digestive Diseases Information Clearinghouse
Nonalcoholic Steatohepatitis National Digestive Diseases Information Clearinghouse National Institute of Diabetes and Digestive and Kidney Diseases NATIONAL INSTITUTES OF HEALTH Nonalcoholic steatohepatitis
More informationAberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary
2015 69 3 137144 Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis a a,b* a a a a a,b a a a,b c d
More informationTransient elastography in chronic liver diseases of other etiologies
4 Post Meeting A.I.S.F. Unmet Clinical Needs in Hepatology: New and upcoming diagnostic tools" Transient elastography in chronic liver diseases of other etiologies Dr. Vincenza Calvaruso Gastroenterologia
More informationFactors associated with waiting time on the liver transplant list: an analysis of the United Network for Organ Sharing (UNOS) database
ORIGINAL ARTICLE Annals of Gastroenterology (2018) 31, 1-6 Factors associated with waiting time on the liver transplant list: an analysis of the United Network for Organ Sharing (UNOS) database Judy A.
More informationChronic liver failure affects multiple organ systems and
ORIGINAL ARTICLES Model for End-Stage Liver Disease (MELD) Predicts Nontransplant Surgical Mortality in Patients With Cirrhosis Patrick G. Northup, MD,* Ryan C. Wanamaker, MD, Vanessa D. Lee, MD, Reid
More informationEvidence Analysis Library Research Project
Evidence Analysis Library Research Project EAL question: What is the evidence to support the use of supplementing BCAA in patients with cirrhosis to 1) prevent further liver damage or improve liver function;
More informationRisk stratification in PBC
Risk stratification in PBC Christophe Corpechot Reference Center for Inflammatory Biliary Diseases Saint-Antoine hospital, Paris, France What is currently known (background) PBC : chronic, progressive
More informationIn the United States, the Model for End-Stage Liver. Re-weighting the Model for End-Stage Liver Disease Score Components
GASTROENTEROLOGY 2008;135:1575 1581 Re-weighting the Model for End-Stage Liver Disease Score Components PRATIMA SHARMA,* DOUGLAS E. SCHAUBEL,, CAMELIA S. SIMA,, ROBERT M. MERION,, and ANNA S. F. LOK* *Division
More informationLuis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Louisville and Louisville VAMC 2015
Luis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Louisville and Louisville VAMC 2015 Protein-calorie malnutrition (PCM) is extremely common
More informationLIVER TRANSPLANTATION FOR OVERLAP SYNDROMES OF AUTOIMMUNE LIVER DISEASES
LIVER TRANSPLANTATION FOR OVERLAP SYNDROMES OF AUTOIMMUNE LIVER DISEASES No conflict of interest Objectives Introduction Methods Results Conclusions Objectives Introduction Methods Results Conclusions
More informationHangzhou, 15 March Ulrich Beuers Department of Gastroenterology and Hepatology Academic Medical Center University of Amsterdam
Clinical Aspects of Primary Biliary Cirrhosis Hangzhou, 15 March 2008 Ulrich Beuers Department of Gastroenterology and Hepatology Academic Medical Center University of Amsterdam Epidemiology of Primary
More informationAutoimmune Hepatitis: Defining the need for Liver Transplantation
Autoimmune Hepatitis: Defining the need for Liver Transplantation Michael A Heneghan, MD, MMedSc, FRCPI. Institute of Liver Studies, King s College Hospital, London Outline Autoimmune Hepatitis Background
More informationWelcome to mmlearn.org
Welcome to mmlearn.org VITAMIN D SUNSHINE VITAMIN INTRODUCTION Familiar with skeletal needs Rickets Osteoporosis Fractures INTRODUCTION Not as familiar other associations Immune system Cancer Cardiovascular
More informationPrognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark
Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark Study of Prognosis of PSC Difficulties: Disease is rare The duration of the course of disease may be very
More informationNutritional Support in Paediatric Patients
Nutritional Support in Paediatric Patients Topic 4 Module 4.5 Nutritional Evaluation of the Hospitalized Children Learning objectives Olivier Goulet To be aware of how malnutrition presents and how to
More informationInterpreting Liver Function Tests
PSH Clinical Guidelines Statement 2017 Interpreting Liver Function Tests Dr. Asad A Chaudhry Consultant Hepatologist, Chaudhry Hospital, Gujranwala, Pakistan. Liver function tests (LFTs) generally refer
More informationNormal ALT for men 30 IU/L 36% US males abnormal. Abnl ALT. Assess alcohol use/meds. Recheck in 6-8 weeks. still pos
Fatty liver disease Its not just for big boys anymore Ken Flora, MD, FAASLD, FACG, AGAF No disclosures Common situation Normal ALT for men 30 IU/L 36% US males abnormal Normal ALT for women 20 IU/L 28%
More informationScreening for HCCwho,
Screening for HCCwho, how and how often? Catherine Stedman Associate Professor of Medicine, University of Otago, Christchurch Gastroenterology Department, Christchurch Hospital HCC Global Epidemiology
More informationIndian Journal of Basic and Applied Medical Research; June 2017: Vol.-6, Issue- 3, P
Original article: Study of usefulness of Discriminant Function (DF) and Glasgow Alcoholic Hepatitis Score (GAHS) in treatment of patients of Alcoholic Hepatitis in Indian Population Dr Mugdha Thakur, Dr
More informationReadmission to the hospital after discharge is an important
Defining Readmission Risk Factors for Liver Transplantation Recipients Neil Shankar, Paul Marotta, MD, William Wall, MD, Mamoun AlBasheer, MD, Roberto Hernandez-Alejandro, MD, and Natasha Chandok, MD,
More informationSurvival of Liver Transplant Recipients With Hemochromatosis in the United States
GASTROENTEROLOGY 2007;133:489 495 Survival of Liver Transplant Recipients With Hemochromatosis in the United States LEI YU*, and GEORGE N. IOANNOU*, *Division of Gastroenterology, Department of Medicine
More informationOcaliva (obeticholic acid tablets)
Ocaliva (obeticholic acid tablets) Policy Number: 5.01.619 Last Review: 11/2018 Origination: 11/2016 Next Review: 11/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage
More informationBMD: A Continuum of Risk WHO Bone Density Criteria
Pathogenesis of Osteoporosis Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis AGING MENOPAUSE OTHER RISK FACTORS RESORPTION > FORMATION Bone Loss LOW PEAK BONE MASS Steven T Harris
More informationPOST TRANSPLANT OUTCOMES IN PSC
POST TRANSPLANT OUTCOMES IN PSC Kidist K. Yimam, MD Medical Director, Autoimmune Liver Disease Program Division of Hepatology and Liver Transplantation California Pacific Medical Center (CPMC) PSC Partners
More informationPBC/AIH variant/ overlap syndrome vs PBC with hepatitic features?
22 November 2018 BD-IAP UK-LPG Liver Update PBC/AIH variant/ overlap syndrome vs PBC with hepatitic features? in a UDCA non-responder Dina G. Tiniakos Institute of Cellular Medicine, Faculty of Medical
More informationMetabolic bone disease, with its predisposition to. Bone Disease in Patients With Primary Sclerosing Cholangitis
GASTROENTEROLOGY 2011;140:180 188 Bone Disease in Patients With Primary Sclerosing Cholangitis PAUL ANGULO,* GARFIELD A. GRANDISON,* DEREK G. FONG,, JILL C. KEACH, KEITH D. LINDOR, EINAR BJORNSSON,, and
More informationNoncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis
Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids Cholestasis Biochemical hallmark Impaired bile flow from liver to small intestine Alkaline phosphatase is primary
More informationNutritional Considerations with Obesity and Bariatric Surgery. Presented by Dr. Ron Grabowski
Nutritional Considerations with Obesity and Bariatric Surgery Presented by Dr. Ron Grabowski January 25, 2010 Nutritional Considerations with Obesity and Bariatric Surgery Presented by Dr. Ron Grabowski
More informationDonor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation
8 Original Article Donor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation Neema Kaseje 1 Samuel Lüthold 2 Gilles Mentha 3 Christian Toso 3 Dominique Belli 2 Valérie McLin 2 Barbara
More informationNAFLD/NASH. Definitions. Pathology NASH. Vicki Shah PA-C, MMS Rush University Hepatology
NAFLD/NASH Vicki Shah PA-C, MMS Rush University Hepatology Definitions NAFLD Evidence of hepatic steatosis by histology (5%) or imaging No causes for secondary fat accumulation EtOH, Drugs, hereditary
More informationOrgan allocation for liver transplantation: Is MELD the answer? North American experience
Organ allocation for liver transplantation: Is MELD the answer? North American experience Douglas M. Heuman, MD Virginia Commonwealth University Richmond, VA, USA March 1998: US Department of Health and
More informationBasic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?
Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need? Rob Goldin r.goldin@imperial.ac.uk Fatty liver disease Is there fatty
More informationCirrhosis: Let s get moving!
Cirrhosis: Let s get moving! Puneeta Tandon Cirrhosis Care Clinic, University of Alberta ADDS 2014 Objectives Physical Deconditioning in Cirrhosis What is it? Why does it happen? Clinical Relevance Potential
More informationZeenat Ali, PGY3 Joseph Grisanti, MD June 7 th, 2012
A Randomized Open Label Trial to Evaluate the Efficacy of Different Dosage Forms of Vitamin D in Patients with Vitamin D Deficiency, and the Effect of Food on Vitamin D Absorption. Zeenat Ali, PGY3 Joseph
More informationLiver Pathology in the 0bese
Liver Pathology in the 0bese Rob Goldin Centre for Pathology, Imperial College r.goldin@imperial.ac.uk Ludwig et al. Non-alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
More informationEarly Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment
American Journal of Transplantation 2016; 16: 850 859 Wiley Periodicals Inc. Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons doi: 10.1111/ajt.13527
More informationHepatocytes produce. Proteins Clotting factors Hormones. Bile Flow
R.J.Bailey MD Hepatocytes produce Proteins Clotting factors Hormones Bile Flow Trouble.. for the liver! Trouble for the Liver Liver Gall Bladder Common Alcohol Hep C Fatty Liver Cancer Drugs Viruses Uncommon
More informationEffect of Body Mass Index on the Survival Benefit of Liver Transplantation
LIVER TRANSPLANTATION 13:1678-1683, 2007 ORIGINAL ARTICLE Effect of Body Mass Index on the Survival Benefit of Liver Transplantation Shawn J. Pelletier, 1 Douglas E. Schaubel, 2,3 Guanghui Wei, 2 Michael
More informationNutrition Management of End- Stage Liver Failure
Nutrition Management of End- Stage Liver Failure Krystel Ouaijan, RDN, MSc Nutrition Support Dietitian in Saint George Hospital UMC PhD in University of Geneva Just few questions https://www.mentimeter.com/s/c1c1be18dc2
More informationRajesh Jain MD Endorama
50 F with history of duodenal switch presenting for low BMD Rajesh Jain MD Endorama HPI 50 F presenting with low BMD referred by PCP She has a history of malnutrition following duodenal switch procedure
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Supplemental Table 1. Distribution of Participants Characteristics by Treatment Group at Baseline - The Vitamin D and calcium (CaD) Trial of the Women s Health Initiative (WHI) Study,
More informationManagement of postmenopausal osteoporosis
Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,
More informationThe authors have declared no conflicts of interest.
Diagnostic Accuracy of Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography Findings in the Postorthotopic Liver Transplant Population Authors: *Ashok Shiani,
More information4/26/2017. Liver Transplant and Palliative Care: Teaming up to improve care
Liver Transplant and Palliative Care: Teaming up to improve care Jody C. Olson, M.D., FACP Assistant Professor of Medicine and Surgery Hepatology and Critical Care Medicine All patients with end-stage
More informationErratum to: Int J Hematol (2014) 99: DOI /s
Int J Hematol (216) 13:725 729 DOI 1.17/s12185-16-1987-1 ERRATUM Erratum to: Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of history
More informationLiving Donor Liver Transplantation Patients Follow-up : Health-related Quality of Life and Their Relationship with the Donor
Showa Univ J Med Sci 29 1, 9 15, March 2017 Original Living Donor Liver Transplantation Patients Follow-up : Health-related Quality of Life and Their Relationship with the Donor Shinji IRIE Abstract :
More informationPBC features and management in the era of UDCA and Budesonide
PBC features and management in the era of UDCA and Budesonide Raoul Poupon, MD Université P&M Curie, AP-Hôpitaux de Paris, Inserm, Paris, France The changing pattern of PBC Over the last 2 decades: More
More informationIncreased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant
ORIGINAL ARTICLE July-August, Vol. 15 No. 4, 2016: 545-549 545 The Official Journal of the Mexican Association of Hepatology, the Latin-American Association for Study of the Liver and the Canadian Association
More informationMalnutrition and nutrition support in patients with liver disease
1 Department of Gastroenterology, Southampton University Hospital Trust, Southampton, UK 2 Southampton University Hospital Trust, Southampton, UK 3 Institute of Human Nutrition, University of Southampton,
More informationORIGINAL ARTICLE. Jun Zheng 1, Rong-chun Xing 1, Wei-hong Zheng 2, Wei Liu 1, Ru-cheng Yao 1, Xiao-song Li 1, Jian-ping Du 1, Lin Li 1.
JBUON 2017; 22(3): 709-713 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE A comparative study on postoperative mortality prediction of SFLI scoring
More informationLong-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance
Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance Gi-Ae Kim, Han Chu Lee *, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim,
More informationIS THERE A DIFFERENCE IN LIVER CANCER RATES IN PATIENTS WHO RECEIVE TREATMENT FOR HEPATITIS?
IS THERE A DIFFERENCE IN LIVER CANCER RATES IN PATIENTS WHO RECEIVE TREATMENT FOR HEPATITIS? Dr. Sammy Saab David Geffen School of Medicine, Los Angeles, USA April 2018 DISCLAIMER Please note: The views
More informationPrevalence of osteoporosis, osteopenia and vitamin d deficiency in cirrhotic patients.
Biomedical Research 2017; 28 (6): 2631-2635 ISSN 0970-938X www.biomedres.info Prevalence of osteoporosis, osteopenia and vitamin d deficiency in cirrhotic patients. Kadri Atay 1, Ibrahim Hatemi 1*, Emre
More informationInterpreting Liver Tests What Do They Mean? Roman E. Perri, MD
Interpreting Liver Tests What Do They Mean? Roman E. Perri, MD The assessment of patients with abnormal liver tests is common in both primary care and gastroenterology clinics. However, among patients
More informationSteatosi epatica ed HCV
Steatosi epatica ed HCV Malattie delle vie biliari ed Epatologia Rho, Auditorium Padri Oblati, 11 Novembre 2006 Piero L. Almasio Università di Palermo HISTOPATHOLOGY Steatosis and accelerated fibrogenesis:
More informationHepatocellular Carcinoma: Epidemiology and Screening
Hepatocellular Carcinoma: Epidemiology and Screening W. Ray Kim, MD Professor and Chief Gastroenterology and Hepatology Stanford University School of Medicine Case A 67 year old Filipino-American woman
More informationThe Impact of Pretransplant Hepatic Encephalopathy on Survival Following Liver Transplantation
LIVER TRANSPLANTATION 21:873 880, 2015 ORIGINAL ARTICLE The Impact of Pretransplant Hepatic Encephalopathy on Survival Following Liver Transplantation Robert J. Wong, 1 Maria Aguilar, 2 Robert G. Gish,
More informationProduct: Denosumab (AMG 162) Clinical Study Report: month Primary Analysis Date: 21 November 2016 Page 1
Date: 21 November 2016 Page 1 2. SYNOPSIS Name of Sponsor: Amgen Inc., Thousand Oaks, CA, USA Name of Finished Product: Prolia Name of Active Ingredient: denosumab Title of Study: Randomized, Double-blind,
More informationNew insights in pathogenesis and therapy of primary biliary cholangitis. Keith D. Lindor Dean Professor of Medicine
New insights in pathogenesis and therapy of primary biliary cholangitis Keith D. Lindor Dean Professor of Medicine OUTLINE PBC Epidemiology Diagnosis Treatment Incidence of PBC and PSC Trends Boonstra
More informationABSTRACT. KEY WORDS antibiotics; prophylaxis; hysterectomy
Infectious Diseases in Obstetrics and Gynecology 8:230-234 (2000) (C) 2000 Wiley-Liss, Inc. Wound Infection in Gynecologic Surgery Aparna A. Kamat,* Leo Brancazio, and Mark Gibson Department of Obstetrics
More informationPrognosis of NASH VII Workshop Intenracional de Actualizaçao em Hepatologia, Aug 29th 2014
Prognosis of NASH VII Workshop Intenracional de Actualizaçao em Hepatologia, Aug 29th 2014 Vlad Ratziu, Université Pierre et Marie Curie, Hôpital Pitié Salpêtrière, Paris, France NASH : a severe hepatic
More informationResearch Article Opioid Use Is Not Associated with Incomplete Wireless Capsule Endoscopy for Inpatient or Outpatient Procedures
Diagnostic and erapeutic Endoscopy, Article ID 651259, 4 pages http://dx.doi.org/10.1155/2014/651259 Research Article Opioid Use Is Not Associated with Incomplete Wireless Capsule Endoscopy for Inpatient
More informationOverview of PSC Jayant A. Talwalkar, MD, MPH Associate Professor of Medicine Mayo Clinic Rochester, MN
Overview of PSC Jayant A. Talwalkar, MD, MPH Associate Professor of Medicine Mayo Clinic Rochester, MN 2012 Annual Conference PSC Partners Seeking a Cure May 5, 2012 Primary Sclerosing Cholangitis Multifocal
More informationMonash Health Referral Guidelines
Monash Health Referral Guidelines CLINICAL NUTRITION EXCLUSIONS Services not offered by Monash Health Psychiatric management of eating disorders consider referring to Eating Disorders Unit Full diagnostic
More informationPancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis
Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis Naoki Tanaka 1, Akira Horiuchi 2, Takahide Yokoyama 3, Shigeyuki Kawa 1, and Kendo Kiyosawa 1 1 Department of Gastroenterology,
More informationCOPD-Related Musculoskeletal Disease. Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017
COPD-Related Musculoskeletal Disease Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017 A 60-year old man with COPD comes into your office for a routine office visit. He is a former
More informationStudy of Lipid Profile Changes in Cirrhosis of Liver
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/187 Study of Lipid Profile Changes in Cirrhosis of Liver Jitendra Kumar Jatav 1, Rajeev Kumar Shakya 2, Sandeep Singh
More informationLiver Cancer: Epidemiology and Health Disparities. Andrea Goldstein NP, MS, MPH Scientific Director Onyx Pharmaceuticals
Liver Cancer: Epidemiology and Health Disparities Andrea Goldstein NP, MS, MPH Scientific Director Onyx Pharmaceuticals 1. Bosch FX, et al. Gastroenterology. 2004;127(5 suppl 1):S5-S16. 2. American Cancer
More informationPresentation and mortality of primary biliary cirrhosis in older patients
Age and Ageing 2000; 29: 305 309 Presentation and mortality of primary biliary cirrhosis in older patients JULIA L. NEWTON 1,DAVID E. JONES 2,JANE V. METCALF 2,JAY B. PARK 2,ALISTAIR D. BURT 2, MARGARET
More information